The AHSN Network has supported many innovators to help advance our health and care system. Find out more about successful innovations supported by the NHS.
Find your nearest AHSN
Innovation and Technology Payment (ITP) Programme
The 2020/21 ITP programme supports NHS England’s commitment to accelerate the adoption and spread of proven and affordable innovations. The programme removes some of the financial and procurement barriers to introducing innovative medical devices, diagnostics and digital product
Pathway Transformation Fund
The Pathway Transformation Fund (PTF) supports NHS organisations to increase adoption of the 2020/21 Rapid Uptake Products (RUPs).
HeartFlow FFRCT for estimating fractional flow reserve (FFR) from coronary CT angiography
Coronary heart disease (CHD) is the world’s number one killer, accounting for 15% of UK deaths in 2019¹. HeartFlow FFRCT analysis provides clinicians with a more efficient pathway for diagnosing CHD that combines simulation models and medical imaging data.
Placental Growth Factor (PlGF) based testing for pre-eclampsia
Pre-eclampsia (PE) affects approximately 3% of all pregnancies and is a serious cause of maternal and foetal morbidity. There is no definitive test to help diagnose PE and the only “cure” is delivery of the baby. High suspicion for the disease and a low threshold for admission places a considerable unnecessary burden on the system, something that PlGF based testing aims to alleviate.
Meru Health remote therapy program for depression, anxiety, and burnout
The Meru Health therapy programme is a structured 12-week remote therapy programme for the treatment of depression, anxiety and burnout.The treatment combines evidence-based exercises and content with continuous support from a personal, licensed therapist, as well as an HRV biofeedback function.- What is Meru Health: https://vimeo.com/429217909- Meru Health's HRV biofeedback feature: https://player.vimeo.com/video/353309977- A participant video testimonial (Finland): https://youtu.be/z8PcUkW8x_Y- A participant video testimonial (US): https://vimeo.com/495477106
patientMpower - remote monitoring in respiratory disease
patientMpower remote monitoring technology (RMT) is currently supporting 2,000+ respiratory disease patients to monitor and manage their condition from home.Clinical studies show patientMpower improves patient well-being and aids achievement of exercise goals and the use of remote spirometry and e-health journals is feasible and acceptable for patients.2021 studies will measure the health economic benefits of RMT in NHS outpatient folllow-up care.
gammaCore for cluster headache pain
GammaCore is a simple-to-use, handheld medical device that enables patients to self-administer discrete doses of non-invasive vagus nerve stimulation (nVNS) therapy to the neck.
Tamoxifen – Licensed repurposed therapies for use in managing breast cancer risk in people with a family history
Of 1000 women who appropriately take Tamoxifen as chemoprevention, 30 will be prevented from developing cancer over a 5-year period. The AAC is launching this project to promote awareness, among primary care clinicians, of prescribing Tamoxifen to reduce the chance of developing breast cancer for women with familial risk of breast cancer
Digital workforce engagement
A happier workforce leads to better patient outcomes and improved performance. ImproveWell is a digital solution for staff engagement and collaboration, improving quality in healthcare. Together, its three feedback systems boost staff morale and empower the frontline to drive change. 24/7 everyone can: suggest ideas for improvement; share how their day at work is going; and complete pulse surveys. An intelligent dashboard helps programme leads to capture real-time data, track workforce sentiment, prioritise quality improvement efforts, and publish reports completing the feedback loop.
Rehabilitation EnAblement in CHronic Heart Failure (REACH-HF)
REACH-HF (Rehabilitation EnAblement in CHronic Heart Failure) is a facilitated evidence based cardiac rehabilitation (CR) and self-management programme for use at home. It comprises the ‘Heart Failure Manual’, a Relaxation CD, a choice of exercise (walking programme or a chair-based DVD) a ‘Progress Tracker’ for patients, and a ‘Family and Friends Resource’ for caregivers.
MetaGuideX receive £50,000 investment through Oxford AHSN Accelerator programme
The Oxford AHSN Accelerator programme, in collaboration with BioCity and regional partners from the NHS, industry and research within the Thames Valley, offers a launchpad for entrepreneurs and their ventures to move from idea to market. MetaGuideX won a place on the intensive eight-week programme and pitched to investors on the final day of the Accelerator programme in November 2020.